Aimin Wu

47.1k total citations · 2 hit papers
232 papers, 5.9k citations indexed

About

Aimin Wu is a scholar working on Pathology and Forensic Medicine, Surgery and Pharmacology. According to data from OpenAlex, Aimin Wu has authored 232 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pathology and Forensic Medicine, 83 papers in Surgery and 40 papers in Pharmacology. Recurrent topics in Aimin Wu's work include Spine and Intervertebral Disc Pathology (81 papers), Spinal Fractures and Fixation Techniques (50 papers) and Musculoskeletal pain and rehabilitation (31 papers). Aimin Wu is often cited by papers focused on Spine and Intervertebral Disc Pathology (81 papers), Spinal Fractures and Fixation Techniques (50 papers) and Musculoskeletal pain and rehabilitation (31 papers). Aimin Wu collaborates with scholars based in China, United States and Hong Kong. Aimin Wu's co-authors include Xiangyang Wang, Xuan-Qi Zheng, Jinfeng Huang, Jie Zhao, Fiona Blyth, Damian Hoy, Emma Smith, Lyn March, Rachelle Buchbinder and Yong-Long Chi and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Aimin Wu

220 papers receiving 5.9k citations

Hit Papers

Global low back pain prevalence and years lived with disa... 2020 2026 2022 2024 2020 2024 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aimin Wu China 39 2.2k 1.6k 1.5k 1.0k 624 232 5.9k
Jie Zhao China 43 1.5k 0.7× 1.4k 0.8× 1.5k 1.0× 2.1k 2.0× 989 1.6× 269 7.5k
Xiangyang Wang China 51 3.6k 1.6× 2.3k 1.4× 2.1k 1.4× 3.5k 3.3× 745 1.2× 320 9.6k
Gen Inoue Japan 49 2.7k 1.2× 2.8k 1.7× 2.3k 1.5× 1.9k 1.8× 511 0.8× 344 9.2k
Feng Zhang China 42 999 0.5× 1.3k 0.8× 512 0.3× 2.5k 2.4× 302 0.5× 345 7.4k
Noriko Yoshimura Japan 51 2.0k 0.9× 3.8k 2.3× 1.7k 1.1× 1.3k 1.3× 834 1.3× 202 9.1k
Giovanni Lombardi Italy 45 874 0.4× 844 0.5× 404 0.3× 1.8k 1.7× 278 0.4× 249 7.2k
Hiroshi Ozawa Japan 38 1.5k 0.7× 1.2k 0.8× 360 0.2× 710 0.7× 274 0.4× 194 4.3k
Chengqi He China 37 396 0.2× 810 0.5× 565 0.4× 1.5k 1.4× 409 0.7× 236 5.4k
Letteria Minutoli Italy 50 1.1k 0.5× 855 0.5× 406 0.3× 2.4k 2.3× 196 0.3× 169 7.3k
Christine L. Le Maitre United Kingdom 47 5.8k 2.6× 2.1k 1.3× 4.4k 3.0× 1.5k 1.4× 1.1k 1.7× 132 8.1k

Countries citing papers authored by Aimin Wu

Since Specialization
Citations

This map shows the geographic impact of Aimin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimin Wu more than expected).

Fields of papers citing papers by Aimin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aimin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimin Wu. The network helps show where Aimin Wu may publish in the future.

Co-authorship network of co-authors of Aimin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Aimin Wu. A scholar is included among the top collaborators of Aimin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aimin Wu. Aimin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Ping, et al.. (2025). Rapeseed protein as a sustainable source of protein in humans: modification of rapeseed meal by physical and chemical methods. Critical Reviews in Food Science and Nutrition. 65(34). 8790–8800. 2 indexed citations
2.
Chen, Junzhou, Mingdao Mu, Yuheng Luo, et al.. (2025). Theaflavins attenuate iron overload-induced liver oxidative injury by inhibiting hepatocyte ferroptosis. International Journal of Biological Sciences. 21(7). 3030–3044. 1 indexed citations
3.
Luo, Wenjing, Yiying Huang, Yi Du, et al.. (2025). External validation of the MOG-AR score for predicting post-attack relapse risk in a chinese cohort with MOGAD. Multiple Sclerosis and Related Disorders. 104. 106829–106829.
4.
Huang, Jiayuan, Sanxin Liu, Peijie Li, et al.. (2024). Multi-omics analysis of gut-brain axis reveals novel microbial and neurotransmitter signatures in patients with arteriosclerotic cerebral small vessel disease. Pharmacological Research. 208. 107385–107385. 2 indexed citations
5.
Heidari, Golnaz, Aimin Wu, Pooyan Makvandi, et al.. (2024). Injectable hydrogels based on biopolymers for the treatment of ocular diseases. International Journal of Biological Macromolecules. 269(Pt 1). 132086–132086. 12 indexed citations
6.
Chen, Zhihua, Linjie Chen, Yihao Xie, et al.. (2024). Targeted mitochondrial nanomaterials in biomedicine: Advances in therapeutic strategies and imaging modalities. Acta Biomaterialia. 186. 1–29. 8 indexed citations
9.
Chen, Qizhu, Yuxin Jin, Tao Chen, et al.. (2024). Injectable nanocomposite hydrogels with enhanced lubrication and antioxidant properties for the treatment of osteoarthritis. Materials Today Bio. 25. 100993–100993. 26 indexed citations
10.
Chen, Linjie, Ke Peng, Qizhu Chen, et al.. (2024). Injectable Hydrogel Based on Enzymatic Initiation of Keratin Methacrylate for Controlled Exosome Release in Intervertebral Disc Degeneration Therapy. Advanced Functional Materials. 34(32). 17 indexed citations
11.
Qian, Qiuping, Pooyan Makvandi, Ehsan Nazarzadeh Zare‬, et al.. (2023). Engineered high-strength biohydrogel as a multifunctional platform to deliver nucleic acid for ameliorating intervertebral disc degeneration. Bioactive Materials. 25. 107–121. 21 indexed citations
12.
Cai, Wei, Xiaohong Chen, Danli Lu, et al.. (2022). Natural Killer Cells Disrupt Nerve Fibers by Granzyme H in Atheriosclerotic Cerebral Small Vessel Disease. The Journals of Gerontology Series A. 78(3). 414–423. 9 indexed citations
13.
Qin, Zongshi, Chang Xu, Joey S.W. Kwong, et al.. (2019). Acupuncture vs Noninsertive Sham Acupuncture in Aging Patients with Degenerative Lumbar Spinal Stenosis: A Randomized Controlled Trial. The American Journal of Medicine. 133(4). 500–507.e20. 18 indexed citations
14.
Chen, C., Dong Chen, Jingwei Zheng, et al.. (2018). Prognostic factors and outcomes of osseous chondrosarcoma after surgery: the 2004–2014 Surveillance, Epidemiology, and End Results database study. Translational Cancer Research. 7(2). 341–346. 1 indexed citations
16.
Feng, Zhenhua, Xiaobin Li, Qian Tang, et al.. (2017). Transforaminal lumbar interbody fusion with cortical bone trajectory screws versus traditional pedicle screws fixation: a study protocol of randomised controlled trial. BMJ Open. 7(10). e017227–e017227. 9 indexed citations
17.
Xu, Haichao, et al.. (2017). The feasibility of building the oblique lumbar interbody fusion corridor: A CT image study. Zhonghua guke zazhi. 37(16). 1021–1028. 1 indexed citations
20.
Wu, Aimin, et al.. (2014). Comparison of two anterior fusion methods in two-level cervical spondylosis myelopathy: a meta-analysis. BMJ Open. 4(7). e004581–e004581. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026